Changes in hepatitis B serologic titers in HIV+ and HIV- children with haemophilia

Haemophilia

Volumn 5, Issue 5, 1999, Pages 354-359

  Kisker, C T ^a   Mahoney, E M ^b   Arkin, S ^c   Maeder, M A ^d   Donfield, S M ^f   Evatt, B L ^e  

^a UNIVERSITY OF IOWA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d PAREXEL INTERNATIONAL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f RHO INC   (United States)

Author keywords

Children; Hepatitis B; HIV

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CHILD; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; VIRUS IMMUNITY;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; HEPATITIS B; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; IMMUNE TOLERANCE; IMMUNITY; MALE;

EID: 0032744907     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1999.00346.x     Document Type: Article

References (14)

1. Buchanan GR, Richards N, Sexaurer CL et al. Serologic response to hepatitis B vaccine in children receiving multiple blood transfusions. Pediatr Infect Dis J 1986; 5: 68-70.
2. Parish DC, Mueeke HW, Joiner TA et al. Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine. South Med J 1991; 84: 426-30.
3. Janco RL. Immunogenicity of subcutaneous hepatitis B vaccine in hemophiliacs. J Pediatr 1985; 107: 316 (Letter).
4. Zanetti AR, Mannucci PM, Tanzi E et al. Hepatitis B vaccination of 113 hemophiliacs: Lower antibody response in anti-LAV/ HTLV-III-positive patients. Am J Hematol 1988; 29: 211-4.
5. Drake JH, Parmley RT, Britton HA. Loss of hepatitis B antibody in human immunodeficiency virus-positive hemophilia patients. Pediatr Infect Dis J 1987; 6: 1051-4.
6. Carne CA, Wellner IVD, Waite J et al. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. Br Med J 1987; 294: 866-8.
7. Laukmamm-Josten U, von Laer G, Feldmeier H et al. Active immunization against hepatitis B. Immunogenicity of a recombinant DNA vaccine in females, heterosexual and homosexual males. Postgrad Med J 1987; 63 (Suppl. 2): 143-6.
8. Biggar RJ, Goedert JJ, Hoofnagle J. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med 1987; 316: 630-1.
9. Laukmamm-Josten U, Muller O, Bienzle U et al. Letter. AIDS 1988; 2: 400-1.
10. Marls JM, Butler RB, Cohen AR. Loss of detectable antibody to hepatitis B surface antigen in immunized patients with hemophilia but without human immunodeficiency virus infection. J Pediatr 1995; 126: 269-71.
11. Bloch DA, Kraemer HC. 2×2 kappa coefficients: Measures of agreement or association. Biometrics 1989; 45: 269-87.
12. Hale CE, Fleiss JL. Interval estimation under two study designs for kappa with binary classifications. Biometrics 1993; 49: 523-34.
13. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
14. Mannucci PM, Zanetti AR, Gringeri A et al. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs. Arch Intern Med 1989; 149: 1333-7.